The Andaz Wall Street
75 Wall Street
New York, NY 10005
NDI Guidance
- Assessing whether the creation of the new ODSP may herald the release of the NDI guidance
- Anticipating the contents of a revised NDI guidance in light of industry contentions from the prior draft NDI release
- Predicting whether the industry’s dissatisfaction with current FDA review and classification procedures for NDIs may be resolved by the revised guidance
'Natural' definition
- Understanding the significance of FDA seeking to define the term natural for the dietary supplements industry
- Review of industry comments
- Anticipating possible next steps by Agency
Proposed Rule on Food Labeling-Revision of the Nutrition and Supplement Facts Label
- Update on status of FDA’s proposed Rule on changes to the Supplement Facts label
- proposed changes vs. present label status
- relationship to proposed changes to the Nutrition Facts label
Speaker:
Claudia A. Lewis, Partner, Venable LLP